171 related articles for article (PubMed ID: 38234462)
1. Celecoxib and cisplatin dual-loaded microspheres synergistically enhance transarterial chemoembolization effect of hepatocellular carcinoma.
Wu K; Ma S; Xu X; Liu Y; Tian C; Zhang C; Shan J; Li Z; Ren K; Ren J; Han X; Zhao Y
Mater Today Bio; 2024 Feb; 24():100927. PubMed ID: 38234462
[TBL] [Abstract][Full Text] [Related]
2. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
[No Abstract] [Full Text] [Related]
3. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
[TBL] [Abstract][Full Text] [Related]
4. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
[TBL] [Abstract][Full Text] [Related]
5. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
6. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Seki A; Hori S
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
[TBL] [Abstract][Full Text] [Related]
7. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
Trials; 2012 Aug; 13():144. PubMed ID: 22913492
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of drug-eluting microspheres designed for transarterial chemoembolization therapy.
Wang Y; Molin DG; Sevrin C; Grandfils C; van den Akker NM; Gagliardi M; Knetsch ML; Delhaas T; Koole LH
Int J Pharm; 2016 Apr; 503(1-2):150-62. PubMed ID: 26965198
[TBL] [Abstract][Full Text] [Related]
9. Idarubicin-Loaded ONCOZENE Drug-Eluting Bead Chemoembolization in a Rabbit Liver Tumor Model: Investigating Safety, Therapeutic Efficacy, and Effects on Tumor Microenvironment.
Borde T; Laage Gaupp F; Geschwind JF; Savic LJ; Miszczuk M; Rexha I; Adam L; Walsh JJ; Huber S; Duncan JS; Peters DC; Sinusas A; Schlachter T; Gebauer B; Hyder F; Coman D; van Breugel JMM; Chapiro J
J Vasc Interv Radiol; 2020 Oct; 31(10):1706-1716.e1. PubMed ID: 32684417
[TBL] [Abstract][Full Text] [Related]
10. Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model.
Gaba RC; Khabbaz RC; Muchiri RN; Morrison JD; Elkhadragy L; Totura WM; Samuelson JP; Whiteley HE; Deaton RL; Nguyen PL; Sverdlov M; Johnson JJ; van Breemen RB; Lokken RP
Drug Deliv Transl Res; 2022 May; 12(5):1105-1117. PubMed ID: 33861419
[TBL] [Abstract][Full Text] [Related]
11. Initial experience with novel Embocure Plus microspheres for transarterial chemoembolization (TACE) of liver metastatic colorectal cancer tumours - a clinical and
Piasecki P; Wierzbicki M; Majewska A; Kieda C; Narloch J
Pol J Radiol; 2021; 86():e136-e142. PubMed ID: 33758639
[TBL] [Abstract][Full Text] [Related]
12. Multimodal imaging of nano-assembled microspheres loaded with doxorubicin and Cisplatin for liver tumor therapy.
He Y; Zhang Y; Gong Y; Zhang Z; Xu T; Tian L; Pan T; Yang H; Pan H; Kou Q; Wang H; Shao G
Front Bioeng Biotechnol; 2022; 10():1024174. PubMed ID: 36213082
[TBL] [Abstract][Full Text] [Related]
13. Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma.
Jia G; Van Valkenburgh J; Chen AZ; Chen Q; Li J; Zuo C; Chen K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1749. PubMed ID: 34405552
[TBL] [Abstract][Full Text] [Related]
14. Superabsorbent Polymer Microspheres Prepared with Hypertonic Saline to Reduce Microsphere Expansion.
Sato T; Tanaka T; Nishiofuku H; Fukuoka Y; Masada T; Tatsumoto S; Marugami N; Morita K; Obayashi C; Hori S; Kaneko M; Kijima A; Kichikawa K
Cardiovasc Intervent Radiol; 2018 Sep; 41(9):1412-1418. PubMed ID: 29850939
[TBL] [Abstract][Full Text] [Related]
15. Engineering polyvinyl alcohol microspheres with capability for use in photothermal/chemodynamic therapy for enhanced transarterial chemoembolization.
Lu X; Liu Q; Yan G; Wang X; Liu X; Tian Q; Song S
J Mater Chem B; 2024 May; 12(21):5207-5219. PubMed ID: 38693796
[TBL] [Abstract][Full Text] [Related]
16. Antitumor properties of arsenic trioxide-loaded CalliSpheres
Duan X; Li H; Han X; Ren J; Li F; Ju S; Wang M; Wang W
Am J Transl Res; 2020; 12(9):5511-5524. PubMed ID: 33042434
[TBL] [Abstract][Full Text] [Related]
17. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
18. Development and physicochemical characterization of a biodegradable microspheres formulation loaded with samarium-153 and doxorubicin for chemo-radioembolization of liver tumours.
Alregib AH; Tan HY; Wong YH; Kasbollah A; Wong EH; Abdullah BJJ; Perkins AC; Yeong CH
J Labelled Comp Radiopharm; 2023 Aug; 66(10):308-320. PubMed ID: 37287213
[TBL] [Abstract][Full Text] [Related]
19. Regorafenib-loaded poly (lactide-co-glycolide) microspheres designed to improve transarterial chemoembolization therapy for hepatocellular carcinoma.
Li X; He G; Su F; Chu Z; Xu L; Zhang Y; Zhou J; Ding Y
Asian J Pharm Sci; 2020 Nov; 15(6):739-751. PubMed ID: 33363629
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable poly(lactide-co-glycolide) microspheres encapsulating hydrophobic contrast agents for transarterial chemoembolization.
Jeon SI; Kim MS; Kim HJ; Kim YI; Jae HJ; Ahn CH
J Biomater Sci Polym Ed; 2022 Mar; 33(4):409-425. PubMed ID: 34613885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
